Patients eligible for anti-IL-5/anti-IL-5Ra treatment in a cohort of adult-onset asthma

P. Ilmarinen (Seinäjoki, Finland), L. Tuomisto (Seinäjoki, Finland), O. Niemelä (Seinäjoki, Finland), H. Kankaanranta (Seinäjoki and Tampere, Finland)

Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Session: Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Session type: Thematic Poster
Number: 1130
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Ilmarinen (Seinäjoki, Finland), L. Tuomisto (Seinäjoki, Finland), O. Niemelä (Seinäjoki, Finland), H. Kankaanranta (Seinäjoki and Tampere, Finland). Patients eligible for anti-IL-5/anti-IL-5Ra treatment in a cohort of adult-onset asthma. 1130

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: